Novo Nordisk made a surprise bid for Metsera to boost its weight-loss market lead, trading at just 12x 2026 EPS. Read why NVO ...
Molecule is claimed to be made from "natural ingredients" such as dandelion root and fennel seed, but investigations tell a different story ...
24/7 Wall St. on MSN
Viking Therapeutics Could Be Pharma’s Next Big Buyout Target
Quick Read GLP-1 market growth is fueling Viking Therapeutics‘ (VKTX) momentum with VK2735 in Phase 3 and VK2809’s NASH ...
Pfizer has filed a lawsuit against Novo Nordisk and Metsera in an attempt to force through its takeover of the weight-loss drug developer and prevent Novo Nordisk from taking its rival bid forward.
Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback